FDA Hosts Virtual Town Hall for the Immediately in Effect Guidance on Coronavirus (COVID-19) Diagnostic Tests
FDA will host a virtual town hall for high-complexity laboratories that are developing molecular diagnostic tests for SARS-CoV-2.
Read MoreSearch Results for: covid-19
FDA and CDC Take Action to Increase Access to Respirators, Including N95s, for Healthcare Personnel
Posted by Steve Halasey | Mar 4, 2020 | Covid 19, Emerging & Zoonotic Diseases, Eyeware & Facial Protection, Infectious Diseases, Lab Safety |
The agencies’ action allows certain National Institute for Occupational Safety and Health-approved respirators not currently regulated by FDA to be used in a healthcare setting by healthcare personnel during the global COVID-19 outbreak.
Read MoreCOVID-19 a Reminder of the Challenge of Emerging Infectious Diseases
Posted by Steve Halasey | Mar 4, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Given the apparent efficiency of virus transmission, everyone should be prepared for COVID-19 to gain a foothold throughout the world, including in the United States.
Read MoreFDA Issues New Policy to Help Expedite Availability of Coronavirus Diagnostics
Posted by Steve Halasey | Mar 3, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
To effectively respond to the COVID-19 outbreak, rapid detection of cases and contacts, appropriate clinical management and infection control, and implementation of community mitigation efforts are critical.
Read MoreLonghorn Vaccines and Diagnostics Encouraged by FDA to Help Solve Coronavirus Testing Bottleneck by Teaming PrimeStore MTM with Diagnostic Developers
Posted by Steve Halasey | Mar 3, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Longhorn’s PrimeStore MTM is the only FDA-cleared nucleic transport device that inactivates microbes within the device allowing for safe transport and testing.
Read More